UNSPSC 51142534: Mofegiline

This classification denotes a monoamine oxidase inhibitor with the molecular formula C11H13F2N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1FMJ6D8Y1B, chemically known as benzenebutanamine, 4-fluoro-beta-(fluoromethylene)-, (e)- but generally known as mofegiline, which bears US NIH Compound Identifier 6437850. European Medicines Agency schedules Mofegiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09034MIG.

UNSPSC 51142534 Mofegiline is a Commodity code that in state and local procurement covers pharmaceutical products and drug-related medical supplies, though recent solicitation activity shows the code being used for naloxone and drug deactivation systems procurement. State and local governments are using this code to source emergency medical countermeasures and harm-reduction supplies for community health and public safety initiatives. The issuing bodies under the code include county health and community services departments, which manage procurement for public health programs including substance-abuse response and overdose prevention.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement required electronic bid submission through the county's e-Procurement Portal, with vendors responsible for all shipping and delivery costs. The initial contract term runs two years with an option for one-year renewal, and bidders were required to meet federal compliance requirements including drug-free workplace certification, E-Verify authorization, and insurance coverage minimums. The procurement cited potential FEMA funding and adherence to federal environmental regulations such as the Clean Air Act and Federal Water Pollution Control Act.